Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionParisi Gray Wealth Management
Latest Disclosed Ownership3,997 shares
Latest Disclosed Value $ 1,406,227
Parisi Gray Wealth Management reports 0.30% decrease in ownership of AMGN / Amgen Inc.

On April 8, 2026 - Parisi Gray Wealth Management filed a 13F-HR form disclosing ownership of 3,997 shares of Amgen Inc. (CH:AMGN) valued at $1,406,227 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 7, 2026 disclosing 4,009 shares of Amgen Inc.. This represents a change in shares of -0.30% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-08 2026-03-31 13F AMGEN COM 031162100 3,997 -12 -0.30 1,406 7.16 0.3350
2026-01-07 2025-12-31 13F AMGEN COM 031162100 4,009 -6 -0.15 1,312 15.80 0.2979
2025-10-17 2025-09-30 13F AMGEN COM 031162100 4,015 7 0.17 1,133 1.25 0.2949
2025-07-08 2025-06-30 13F AMGEN COM 031162100 4,008 -30 -0.74 1,119 -11.05 0.3207
2025-04-14 2025-03-31 13F AMGEN COM 031162100 4,038 11 0.27 1,258 19.92 0.4108
2025-01-13 2024-12-31 13F AMGEN COM 031162100 4,027 13 0.32 1,050 -18.87 0.3336
2024-10-07 2024-09-30 13F AMGEN COM 031162100 4,014 -11 -0.27 1,293 2.86 0.4270
2024-07-15 2024-06-30 13F AMGEN COM 031162100 4,025 -83 -2.02 1,257 7.71 0.4508
2024-04-15 2024-03-31 13F AMGEN COM 031162100 4,108 -7 -0.17 1,168 -1.52 0.4381
2024-01-18 2023-12-31 13F AMGEN COM 031162100 4,115 -8 -0.19 1,185 6.95 0.4802
2023-10-10 2023-09-30 13F AMGEN COM 031162100 4,123 -105 -2.48 1,108 8.41 0.5032
2023-07-14 2023-06-30 13F AMGEN COM 031162100 4,228 2,721 180.56 1,022 180.77 0.4670
2023-04-11 2023-03-31 13F AMGEN COM 031162100 1,507 -2,744 -64.55 364 -67.38 0.2265
2023-01-23 2022-12-31 13F AMGEN INC COM EQUITY 031162100 4,251 2,642 164.20 1,117 207.44 0.5498
2022-10-19 2022-09-30 13F AMGEN INC COM EQUITY 031162100 1,609 -2,693 -62.60 363 -65.33 0.2763
2022-07-25 2022-06-30 13F AMGEN INC COM EQUITY 031162100 4,302 -306 -6.64 1,047 -6.01 0.5469
2022-05-13 2022-03-31 13F AMGEN INC COM EQUITY 031162100 4,608 -303 -6.17 1,114 0.81 0.4512
2022-02-08 2021-12-31 13F AMGEN INC COM Equity 031162100 4,911 -131 -2.60 1,105 2.41 0.4131
2021-11-16 2021-09-30 13F AMGEN INC COM Equity 031162100 5,042 -96 -1.87 1,079 -13.82 0.4464
2021-08-13 2021-06-30 13F AMGEN INC COM Equity 031162100 5,138 -121 -2.30 1,252 -4.28 0.4585
2021-05-17 2021-03-31 13F AMGEN INC COM Equity 031162100 5,259 31 0.59 1,308 8.82 0.5459
2021-02-09 2020-12-31 13F AMGEN INC COM Equity 031162100 5,228 0 0.00 1,202 -9.56 0.5329
2020-11-10 2020-09-30 13F AMGEN INC COM Equity 031162100 5,228 -86 -1.62 1,329 6.07 0.6908
2020-07-27 2020-06-30 13F AMGEN INC COM Equity 031162100 5,314 0 0.00 1,253 16.34 0.7184
2020-05-13 2020-03-31 13F AMGEN INC COM Equity 031162100 5,314 -20 -0.37 1,077 -16.25 0.7626
2020-01-24 2019-12-31 13F AMGEN INC COM Equity 031162100 5,334 1 0.02 1,286 24.61 0.7275
2019-10-09 2019-09-30 13F AMGEN INC COM EQUITY 031162100 5,333 -52 -0.97 1,032 4.03 0.6842
2019-07-19 2019-06-30 13F AMGEN INC COM EQUITY 031162100 5,385 0 0.00 992 -3.03 0.6751
2019-05-14 2019-03-31 13F AMGEN INC COM Equity 031162100 5,385 -10 -0.19 1,023 -0.58 0.6536
2019-02-12 2018-12-31 13F AMGEN INC COM Equity 031162100 5,395 10 0.19 1,029 -8.53 0.6974
2018-11-13 2018-09-30 13F AMGEN INC COM Equity 031162100 5,385 0 0.00 1,125 9.33 0.6929
2018-08-13 2018-06-30 13F AMGEN INC COM Equity 031162100 5,385 -2 -0.04 1,029 13.58 0.6857
2018-05-11 2018-03-31 13F AMGEN INC COM Equity 031162100 5,387 2 0.04 906 -4.93 0.6942
2018-02-13 2017-12-31 13F AMGEN INC COM Equity 031162100 5,385 5,385 953 0.7113
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.